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Riboswitches are RNA-based genetic control
elements that regulate gene expression in a
ligand-dependent fashion without the need for
proteins. The ability to create synthetic ribos-
witches that control gene expression in re-
sponse to any desired small-molecule ligand
will enable the development of sensitive genetic
screens that can detect the presence of small
molecules, as well as designer genetic control
elements to conditionally modulate cellular be-
havior. Herein, we present an automated high-
throughput screening method that identifies
synthetic riboswitches that display extremely
low background levels of gene expression in
the absence of the desired ligand and robust in-
creases in expression in its presence. Mecha-
nistic studies reveal how these riboswitches
function and suggest design principles for cre-
ating new synthetic riboswitches.We anticipate
that the screening method and design princi-
ples will be generally useful for creating func-
tional synthetic riboswitches.
INTRODUCTION
Riboswitches are RNA-encoded genetic control elements
that regulate gene expression in a ligand-dependent fash-
ion without the need for proteins [1–3]. Riboswitches are
comprised of an aptamer domain, which recognizes the
ligand, and an expression platform, which couples ligand
binding to changes in gene expression [1, 4]. Riboswitches
are widespread in prokaryotes [5–8], and more recent
studies have revealed that riboswitches also control
gene expression in eukaryotes [9, 10]. In addition to natural
riboswitches that control gene expression in response to
endogenous metabolites, a variety of synthetic ribos-
witches that respond to nonendogenous small molecules
have been developed [11–16]. In principle, synthetic ribo-
switches can be engineered to respond to any nontoxic,
cell-permeable molecule that is capable of interacting
with an RNA. As such, synthetic riboswitches representChemistry & Biology 14, 173–1versatile ligand-dependent gene expression systems
with great potential to detect the production of small mol-
ecules for applications in directed evolution or metabolic
engineering. While methods to select aptamers that bind
to small molecule targets are well established [17], general
methods of converting these aptamers into riboswitches
that function optimally in prokaryotic cells are not. To fully
exploit their potential, it is critical to develop new methods
to create synthetic riboswitches that function in bacteria.
A variety of methods have been used to create synthetic
riboswitches that control eukaryotic transcription or trans-
lation. Werstuck and Green created synthetic ribo-
switches that regulate translation by cloning aptamer se-
quences into the 50 untranslated regions (50UTR) of
eukaryotic mRNA sequences. Binding of the ligand in-
creased the strength of the RNA secondary structure in
the 50UTR and reduced the translation of downstream
coding regions [16]. This approach was adopted by the
groups of Wilson [12], Pelletier [13], and Suess [15] to cre-
ate synthetic riboswitches that repress eukaryotic protein
translation in response to small molecule ligands. Buskirk
et al. [18] created an aptamer-based transcriptional con-
trol system that promotes ligand-dependent transcription
in yeast, and Gaur and coworkers used an aptamer to
control ligand-dependent RNA splicing in vitro [19]. In ad-
dition to systems where regulation occurs in cis, a variety
of riboregulators have been used to affect eukaryotic
translation in trans [20–23].
Given that most natural riboswitches have been identi-
fied in prokaryotes, it is perhaps surprising that there are
relatively few examples of synthetic riboswitches that
function in bacteria. Suess et al. [14] created a riboswitch
based on a designed helix-slipping mechanism that acti-
vates protein translation in a theophylline-dependent man-
ner in the Gram-positive bacterium B. subtilis, and we re-
ported a theophylline-sensitive riboswitch that activates
protein translation in the Gram-negative bacterium E. coli
[11]. While our previously reported synthetic riboswitches
were useful in several contexts, three important issues
remained unresolved. First, these switches did not com-
pletely repress protein translation in the absence of the li-
gand. Second, the most effective switch showed a signal
to background ratio (activation ratio) of approximately
eight in the presence of 500 mM theophylline. While this
8-fold increase allowed us to perform both genetic screens84, February 2007 ª2007 Elsevier Ltd All rights reserved 173
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High-Throughput Screen for Synthetic RiboswitchesFigure 1. Diagramof the 50 Region of a Synthetic Riboswitch, the Performance of the Synthetic Riboswitch, and theRandomization
Strategy
(A) Sequence of a portion of the 50 region of the parent synthetic riboswitch with 8 bases separating the aptamer (green) and the ribosome binding site
(pink); the AUG start codon (peach) is highlighted. The aptamer is shown in the secondary structure predicted for the theophylline aptamer by mFold
and confirmed experimentally.
(B) Measures of the activity of the synthetic riboswitch shown in (A) when cloned upstream of the IS10-lacZ gene fusion and expressed in E. coli. Right
axis: b-galactosidase activity in the absence (open circle) or presence of theophylline (1 mM, closed circle). Activities are expressed in Miller units, and
the standard errors of the mean are less than the diameters of the circles. Left axis: the activation ratio of the synthetic riboswitch (gray bar), which is
determined by taking the ratio of the activities in the presence and absence of theophylline.
(C) Sequence diagram of the randomized synthetic riboswitches. The aptamer is shown in green, the randomized regions in light blue, the ribosome
binding site in pink, and the AUG start codon in peach. Theoretical library sizes are shown in the circle.and selections to detect the presence of theophylline, for
more demanding screening applications, an increase in
the ratio of signal to background is desirable. Finally, while
we determined that these riboswitches operated posttran-
scriptionally, we were unable to determine their precise
mechanisms of action. To address these issues, we devel-
oped a high-throughput screen that enables the identifica-
tion of synthetic riboswitches that display very low back-
ground levels of translation in the absence of ligand and
dramatically higher signal-to-background ratios. Se-
quence analysis allowed us to propose and test a model
for synthetic riboswitch function and to also explain the
mechanism of action of our previously reported synthetic
riboswitches. Our results show that starting from a single
aptamer, there are many different ways to create functional
riboswitches, consistent with the notion that natural ribo-
switches may be derived from small-molecule-binding
RNA aptamers that were subsequently recruited to
regulate gene expression. We anticipate that the high-
throughput assay described herein will be generally useful
for discovering synthetic riboswitches with new ligand
specificities and better performance characteristics.
RESULTS AND DISCUSSION
We previously observed that changing the length of the se-
quence separating the theophylline aptamer and the ribo-
some binding site (RBS) had dramatic effects on both the
function and dynamic range of a synthetic riboswitch
[11]. However, we could not determine precisely how these
changes exerted their effects. We anticipated that by ran-174 Chemistry & Biology 14, 173–184, February 2007 ª2007domizing the RNA sequence in this region and screening
the library for function, we could identify improved
switches and possibly gain insight into their mechanisms
of action. Because the sequence space of RNA is relatively
small, most, if not all, potential sequences can be sampled
in the context of a simple genetic screening experiment.
Creation of a Library of Randomized Mutants
We previously created synthetic riboswitches by cloning
a theophylline-binding aptamer [24–27] at various loca-
tions upstream of the ribosome binding site of a b-galac-
tosidase reporter gene (IS10-lacZ) that was controlled at
the transcriptional level by a weak, constitutively active
IS10 promoter (Figure 1A). To increase the overall signal,
we replaced the IS10 promoter with the stronger Ptac1
promoter [28]. As expected, the tac promoter enhances
the level of b-galactosidase expression in the presence
of theophylline but also increases the background expres-
sion 80-fold from 10 Miller units [11] to 800 Miller
units (Figure 1B).
We used cassette-based PCR mutagenesis to create
five different libraries in which the distance between the
aptamer and the RBS was varied between 4 and 8 bases,
and the sequence was randomized fully (Figure 1C)
because we previously observed that longer or shorter
spacings resulted in poorly functioning switches [11].
High-Throughput Screen for Optimally Functioning
Riboswitches
To screen the libraries, E. coli were transformed with plas-
mids harboring randomized sequences of a given lengthElsevier Ltd All rights reserved
Chemistry & Biology
High-Throughput Screen for Synthetic RiboswitchesFigure 2. Diagram of the High-Through-
put Assay
Candidate riboswitches are identified by plat-
ing cells onto selective media containing X-
gal but no theophylline. A robotic colony picker
identifies the whitest colonies (lowest levels of
b-galactosidase activity) and transfers the cells
to a 96-well microtiterplate. The culture is
grown overnight in selective media, split, and
the clones are tested for b-galactosidase activ-
ity by using the automated assay described in
the text.and were grown on selective agar plates in the presence of
X-gal (the substrate for b-galactosidase), but in the ab-
sence of theophylline. Most (99%) clones appeared
blue, indicating that they were expressing b-galactosidase
in the absence of theophylline. However, in all libraries,
a number of colonies appeared white, suggesting little to
no b-galactosidase expression. To identify whether these
colonies harbored riboswitches that could activate protein
translation in the presence of theophylline, we used a
colony-picking robot to isolate the whitest colonies from
each plate of approximately 4000 colonies (Figure 2).
These clones were inoculated into 96-well microtiterplates
containing selective LB media. These cultures were grown
overnight and were used to inoculate two new 96-well
plates that either contained theophylline (0.5 mM) or did
not. These plates were grown at 37C with shaking for
2–2.5 hr, and b-galactosidase activity was assayed using
an adaptation of Miller’s method performed either by hand
with a multichannel pipettor or by using a robotic liquid-
handling system [29–31]. Ratios of the Miller units for cul-
tures grown in the presence of theophylline to those grown
without theophylline (the ‘‘activation ratio’’) were utilized to
identify functional switches.
To validate the screen, we chose clones that displayed
an activation ratio of greater than two and assayed them
individually in larger cultures, but we discovered that
less than half of these clones functioned as switches. Fur-
ther analysis indicated that these irregularities were due to
a number of factors, including small but significant differ-
ences in the growth rates and lysis efficiencies of the cells
in the microtiterplates. To improve the accuracy of identi-
fying functional synthetic riboswitches, we performed
each assay in duplicate and analyzed the data by an em-
pirically derived procedure in which we retained candi-
dates that: (1) showed an activation ratio of greater than
2.0 in two separate determinations, (2) displayed a mini-
mum level of b-galactosidase activity in the presence of
theophylline (an OD420R 0.04 in the Miller assay, regard-
less of cell density), (3) grew normally relative to others in
the plate (as represented by OD600), and (4) showed con-
sistent results between the two plates. This simple analy-
sis significantly reduced the number of potential candi-
dates, of which greater than 90% were confirmed as
functional synthetic riboswitches when assayed individu-
ally in larger volumes of culture. For the small number of
candidates that were not validated, sequencing often
revealed mixed populations of plasmids that were likelyChemistry & Biology 14, 173–introduced during colony picking, and plating cells at
lower densities minimized such events.
Figure 3 shows statistics for the libraries and the results
from the top validated hits identified in each of these
screens. For each sequence length, the absolute levels
of b-galactosidase activity in the presence and absence
of theophylline (1 mM) are plotted, as well as the ratio of
these numbers (activation ratio) for the switches that dis-
played the highest activation ratios. From these data, it
is clear that the high-throughput screening method is ca-
pable of identifying riboswitches that display both low
background levels of protein expression in the absence
of ligand and strong increases in the presence of the li-
gand. Indeed, the best clone identified (8.1) displays
a 36-fold increase in protein expression in the presence
of theophylline and a very low level of expression in its
absence. To put this in perspective, natural riboswitches
that regulate protein translation (though, most of these
switches repress protein translation) show repression ra-
tios of about 100 in the presence of the ligand [7]. The dis-
covery of switches that function within a factor of three
of natural genetic regulatory elements that have evolved
over considerably longer time periods suggests that this
screening method is quite effective and that creation of
new synthetic riboswitches based on different aptamers
may be straightforward.
Sequencing Suggests a Possible Mechanism
of Action for Synthetic Riboswitch Function
In addition to identifying synthetic riboswitches that dis-
play excellent performance characteristics, these screens
provided a wealth of sequence information that allowed us
to propose and test models for riboswitch function. Visual
sequence analysis revealed several conserved or semi-
conserved motifs that are complementary to different re-
gions of the theophylline aptamer. Shown in Figure 4 are
the mFold-predicted [32, 33] secondary structures of
two of the new synthetic riboswitches in the region ex-
tending from the 50 end of the aptamer to the 30 end of
the AUG start codon of the IS10-lacZ gene. On the left-
hand side are the two minimum energy structures—in
both cases, the bases between the aptamer and the
RBS are paired with the aptamer sequence, suggesting
that translation might be inhibited in the absence of the li-
gand. On the right-hand side of Figure 4, the experimen-
tally determined secondary structure for the theophyl-
line-binding aptamer [24–27] appears in the calculated184, February 2007 ª2007 Elsevier Ltd All rights reserved 175
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High-Throughput Screen for Synthetic RiboswitchesFigure 3. Analysis of Libraries and Results from Screens
(A) Statistics for libraries assayed.
(B–E) Measures of the activities of the synthetic riboswitches identified in the high-throughput screens. Each measurement is done in triplicate. For all
panels: right axis, b-galactosidase activity in the absence (open circle) or presence of theophylline (1 mM, closed circle). Activities are expressed in
Miller units, and the standard errors of the mean are less than the diameters of the circles. Left axis, the activation ratio of the synthetic riboswitches
(gray bar), which are determined by taking the ratio of the activities in the presence and absence of theophylline.structure and the RBS is not paired—in both cases, the
calculated differences in free energy between the two
structures are less than the free energy of theophylline
binding (9.2 kcal/mol) [24], suggesting that conversion
between the structures is thermodynamically favorable
in the presence of theophylline. All of the synthetic ribos-
witches identified in our screens can be folded into one
of the two folding motifs (‘‘blue’’ or ‘‘red’’) shown in Figure 4
(sequences and their motifs are reported in the Supple-
mental Data available with this article online).
The folds in Figure 4 suggest a possible switching
mechanism in which extensive pairing in the region near
the ribosome binding site prevents translation of b-galac-
tosidase in the absence of theophylline. Such behavior
is consistent with the studies of de Smit and van Duin
who demonstrated that secondary structure near the
ribosome binding site dramatically reduces the translation176 Chemistry & Biology 14, 173–184, February 2007 ª2007 Elof the mRNA downstream [34–36]. Theophylline binding
(DGbind  9.2 kcal/mol) could in principle drive the equi-
librium toward the structures on the right, in which the
known secondary structure of the aptamer is present
[25] and the ribosome binding sites are unpaired, which
would increase the efficiency of translation.
To test whether base-pairing between the aptamer and
a region near the ribosome binding site was important
for function, we performed covariance experiments in
which we mutated these bases to disrupt the putative
base-pairing (Figure 5). Removal of several putative base
pairs in clone 8.1 increased b-galactosidase expression
5-fold in the absence of the ligand, while restoring the
base-pairing by mutating the aptamer sequence de-
creased the background level of b-galactosidase expres-
sion to its original level, consistent with the pairing hypoth-
esis. Because these mutations also affect theophyllinesevier Ltd All rights reserved
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High-Throughput Screen for Synthetic RiboswitchesFigure 4. Predicted Mechanisms of Action of Synthetic Riboswitches
(A) Predicted mechanism of action of clone 8.1. In the absence of theophylline (left), the 50 region can adopt a highly folded structure that extensively
pairs the region that includes ribosome binding site to part of the aptamer sequence (shown in dark blue). In the presence of theophylline (right), the
secondary structure shifts, such that the ribosome binding site is exposed. The secondary structure shown for the theophylline aptamer predicted by
mFold and is identical to the structure determined by NMR.
(B) Predicted mechanism of action of clone 8.2. In this case, the region containing the ribosome binding site pairs to a different region of the aptamer in
the ‘‘off’’ state (shown in red). This demonstrates that several motifs may function as synthetic riboswitches.binding, these mutants were not active in the presence of
theophylline [26].
In light of these results that suggest that pairing in the re-
gion between the aptamer and the ribosome binding site is
important for riboswitch function, we revisited the activa-
tion data from our previously reported synthetic ribos-
witches [11]. In creating those switches, we did not explic-
itly engineer or screen for any particular sequence in this
region. Reexamination of our previously reported ribos-
witch (Figure 1A) revealed that a 7 base sequence located
27 bases after the start codon of the IS10-lacZ reporter
gene (UUUCUCU) is the precise reverse complement of
the bases between the aptamer and the ribosome binding
site. To test whether these regions pair to suppress geneChemistry & Biology 14, 173–18expression in the absence of theophylline, we deleted the
N-terminal IS10 fusion (pSALWT-DIS10). If bases within
the IS10 sequence pair to suppress gene expression in
the absence of theophylline, deleting this region should in-
crease gene background levels of expression. Consistent
with this model, deletion of the IS10 sequence increased
the b-galactosidase activity in the absence of theophylline
approximately 15-fold (from 800 to over 12,000 Miller
units), confirming that the previously reported synthetic
riboswitches depended on the presence of the IS10
sequence to function.
The models proposed in Figure 4 predict that all of
the necessary elements to control gene expression are
located in the 50UTR, suggesting that the sequence of4, February 2007 ª2007 Elsevier Ltd All rights reserved 177
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High-Throughput Screen for Synthetic RiboswitchesFigure 5. Results from Covariance Experiments
b-galactosidase activities in the absence of theophylline (open circles) for the parent synthetic riboswitch (clone 8.1) (left), a triple mutant that unpairs
the region near the ribosome binding site (center), and a mutant that restores the pairing (right). Activities are expressed in Miller units (shown on the
left axis); the standard errors of the mean are less than the diameters of the circles. For each construct, the predicted secondary structure is shown in
the region near the ribosome binding site. The parent and covariant maintain the pairing and show low background levels of b-galactosidase activity.
The mutant unpairs this region and leads to leaky expression in the absence of theophylline.the downstream gene should not impact the function of
the switch. To test this, we replaced the entire 50UTR
of the ‘‘leaky’’ pSALWT-DIS10 construct with the 50UTR
from clone 8.1. Gratifyingly, this construct (pSKD8.1-
DIS10) behaved nearly identically to clone 8.1, with low
background levels of b-galactosidase expression in the
absence of theophylline and a strong increase in b-galac-
tosidase expression in the presence of theophylline (data
not shown). Furthermore, we cloned the entire 50UTR from
clone 8.1 upstream of several reporter genes that lack the
N-terminal IS10 fusion, including gfp, dsRED, and cat.
These switches all function well and do not depend on
the sequence of the gene downstream (S.A.L., H.K.S.,
and J.P.G., unpublished data). Taken together, these ex-
periments and the covariance experiments above strongly
implicate a functional role for the region between the ap-
tamer and the RBS, and the results are consistent with
the RNA folds shown in Figure 4.
A Model for Synthetic Riboswitch Function
Our data suggest that these synthetic riboswitches dis-
play low background levels of translation in the absence
of ligand and robust increases in the presence of the li-
gand for two reasons. The first is that in the absence of
the ligand, the ribosome binding site is paired in such
a way that translation is minimized. The second is that li-
gand binding drives the RNA to a conformation in which
the RBS is unpaired. As described by de Smit and van
Duin [34–36], sequences with pairing near the ribosome
binding site typically display reduced translation rates be-178 Chemistry & Biology 14, 173–184, February 2007 ª2007 Ecause the 30S subunit of the ribosome binds most effi-
ciently to single-stranded regions of RNA. Since transla-
tion is the slow step in protein production, the position
of a pre-equilibrium between RNA structures that have
the ribosome binding site paired or unpaired will factor
directly into the rate expression for protein synthesis.
Sequences that strongly favor pairing of the ribosome
binding site are likely to show minimal levels of protein
translation in the absence of ligand, since translation is
very inefficient when the RBS is paired. Even if such se-
quences equilibrate with higher-energy structures where
the RBS is unpaired (and translation is efficient), the rela-
tive population of these high-energy states, and thus the
overall translation rate, will be low. The relative stabilities
of these structures will dictate the background levels of
translation in the absence of the ligand. However, if addi-
tion of the ligand shifts the population of mRNAs to a struc-
ture(s) where many of the ribosome binding sites are un-
paired, this model predicts robust increases in protein
translation from these efficiently translated mRNAs.
Figure 6A shows the predicted secondary structures
and free energies of the region of the mRNA of clone 8.1
extending from the 50 end of the aptamer to the 30 end of
the start codon. In the minimum-energy structure (‘‘Off,’’
left), the RBS is paired. In the middle is the lowest energy
structure (DDG = +5.5 kcal/mol; see the Supplemental
Data for the folding protocol) in which the ribosome bind-
ing site is predicted to be unpaired (‘‘On’’); this is also the
lowest energy structure in which the secondary structure
of the aptamer is present. On the right is the samelsevier Ltd All rights reserved
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(A) Predicted structures and free energies of a portion of the 50 region of clone 8.1 determined by mFold. To represent the free energies of the bound
structures, we added the experimentally determined free energy of theophylline binding (9.2 kcal/mol) to the free energy of the unliganded structure
determined by mFold since the secondary structure of the mTCT-8-4 aptamer does not change upon ligand binding.
(B) Kinetic model for synthetic riboswitch function. In the ‘‘Off’’ state, the ribosome binding site is paired and translation is slow (represented by the
pseudofirst-order rate constant k1 obs, which accounts for ribosome binding and translation). The ‘‘Off’’ state is proposed to be in equilibrium with the
ligand-free ‘‘On’’ state, in which the ribosome binding site is unpaired and translation is relatively fast (represented by the pseudofirst-order rate con-
stant k2 obs, which is much greater than k1 obs). Since this state is not highly populated, background translation is minimal. Addition of ligand (L) shifts
the equilibrium to the ligand-bound ‘‘OnL’’ state, in which the ribosome binding site is unpaired and translation is relatively fast (represented by the
pseudofirst-order rate constant k3 obs, which is also much greater than k1 obs).calculated fold, but the free energy has been lowered by
9.2 kcal/mol, the experimentally determined free energy
of theophylline binding (‘‘OnL’’).
An equilibrium model predicts that in the absence of
the ligand, the majority of the RNA population adopts the
‘‘Off’’ structure in which the RBS is paired because the
‘‘On’’ structure is significantly uphill in free energy. Addi-
tion of theophylline provides the thermodynamic driving
force to shift the equilibrium toward the ‘‘OnL’’ structure.
These observations can be represented in the model
shown in Figure 6B, where the pseudofirst-order rate con-
stants (kobs 1, kobs 2, and kobs 3) include the rates of ribo-
some binding and the initiation of translation and the con-
centration of the 30S ribosomal subunit. The studies of de
Smit and van Duin [34–36] predict that the translation effi-
ciency from the ‘‘Off’’ structure, in which the ribosome
binding site is paired, would be significantly lower than
the efficiency from the structures in which the RBS is un-
paired (‘‘On’’ and ‘‘OnL’’), thus kobs 1 <<< kobs 2z kobs 3.
Thus, in the absence of ligand, the overall translation rate
would be low, and the rate would increase in the presence
of the ligand.
While this model qualitatively fits our experimental ob-
servations, determining accurate rate constants and
mRNA concentrations in vivo is very challenging. Never-
theless, we can test elements of the model, such as the
ability of RNA structures to equilibrate in the presence of
the ligand. Demonstrating that an mRNA transcript can
undergo a ligand-inducible shift from an untranslated
state into a translated state in vivo would provide evidence
for the equilibrium model proposed above and would also
argue against a kinetic model, in which the committed
step for translation occurs during transcription (i.e., a tran-
script is translated only if the appropriate ligand is present
at the time of transcription) (Figure 7A) [37, 38].Chemistry & Biology 14, 173To test these models, E. coli that were constitutively
transcribing a riboswitch-controlled lacZ gene were
grown in the absence of theophylline. Theophylline was
added and the b-galactosidase expression at various
time points was assayed using Miller’s method (Figure 7B).
b-galactosidase activity (as measured by A420) first ap-
pears approximately 200 s after the addition of theophyl-
line and continues to increase at a steady rate. During
the 200 s before b-galactosidase activity appears, several
events must occur: (1) theophylline must enter the cell, (2)
it must bind to the mRNA, (3) it must induce switching, (4)
the ‘‘switched’’ mRNA must be translated, and (5) b-galac-
tosidase must fold and become active. Liang et al. have
shown b-galactosidase activity in E. coli appears within
60 s upon using IPTG to initiate transcription of lacZ [39].
Their results show that transcription rate of lacZ must be
at least 57 nt/s (3420 nt/60 s) and that the subsequent
acts of translation, folding, and appearance of b-galacto-
sidase activity must collectively take less than 60 s [39].
After accounting for the 60 s required for translation, fold-
ing, and the appearance of enzymatic activity, the fact that
we do not observe b-galactosidase activity until 200 s
after theophylline addition suggests that collectively
theophylline entry, binding, and switching may take up
to 140 s. Although this delay could be consistent with a ki-
netic barrier for interconversion between a nontranslatable
mRNA and a translatable mRNA, we cannot yet determine
whether such conformational changes are responsible for
the switching behavior.
An alternative to a theophylline-driven equilibrium
model is a ‘‘kinetic’’ mechanism whereby the fate of an
mRNA is determined at the time of transcription. Much
of the data thus far can also be explained in terms of a
cotranscriptional kinetic model in which the majority of
the mRNA pool folds into a non- or weakly translatable–184, February 2007 ª2007 Elsevier Ltd All rights reserved 179
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(A) Top, a thermodynamic model for riboswitch function. Newly synthesized RNA adopts a folded conformation that prevents translation (‘‘Off’’). Ad-
dition of theophylline can drive the conformation to the ‘‘On-L’’ conformation. Bottom, a kinetic model in which a newly synthesized RNA adopts either
an ‘‘Off’’ or an ‘‘On-L’’ conformation depending on whether ligand is present during transcription; however, the ‘‘Off’’ and ‘‘On-L’’ conformations do
not equilibrate.
(B) Time course for appearance of b-galactosidase activity (measured by ONPG hydrolysis) for clone 8.1. Theophylline was added at t = 0 to a final
concentration of 3 mM; significant activity appears at 200 s.
(C) Time course for appearance of b-galactosidase activity (measured by ONPG hydrolysis) for clone 8.1. Theophylline was added at t = 0 to a final
concentration of 3 mM; rifampicin was added at the times shown in the legend. Rifampicin does not eliminate b-galactosidase activity when added up
to 40 s prior to the addition of theophylline, supporting the thermodynamic model shown in (A) in which theophylline can induce expression even in the
absence of active transcription. Error bars are ± SD.conformation when theophylline is not present (e.g., the
‘‘Off’’ conformation shown in Figure 7A). If theophylline
can induce some fraction of the mRNA to fold into the
highly translatable ‘‘On-L’’ conformation, theophylline-
dependent activation of translation could occur regard-
less of whether the translatable and nontranslatable mRNA
conformations can interconvert. Given that (1) lacZ trans-
cription is fast (60 nt/s) [39], (2) both mRNA folding and
translation occur cotranscriptionally in E. coli, (3) the entire
‘‘functional unit’’ of the riboswitch is located within the first
100 transcribed bases, and (4) the proposed ‘‘On’’ and180 Chemistry & Biology 14, 173–184, February 2007 ª2007 Els‘‘Off’’ conformations are both small hairpins, it is extremely
likely that the fate (translatability) of an mRNA is deter-
mined within seconds of the initiation of transcription. As
such, theophylline would have to be present during tran-
scription for b-galactosidase activity to be observed.
To test whether b-galactosidase expression is depen-
dent on the presence of theophylline while transcription
is active, we used the antibiotic rifampicin to halt tran-
scription and asked whether subsequent addition of
theophylline could induce b-galactosidase expression.
Rifampicin prevents RNA polymerase from entering theevier Ltd All rights reserved
Chemistry & Biology
High-Throughput Screen for Synthetic Riboswitcheselongation phase following the initiation of transcription,
but it has no effect on RNA polymerase once it has
reached the elongation phase [39]. The quick action of
rifampicin (5 s), coupled with the fast elongation rate of
E. coli RNA polymerase (60 nt/sec) [39], suggests that
within 10 s of rifampicin addition, no new transcripts
are being produced, and any elongating transcripts
are 100 nt beyond the 50UTR.
Figure 7C shows the theophylline-induced expression
of b-galactosidase from cultures harboring switch 8.1 in
which rifampicin was added 0, 20, 40, or 60 s prior to
the addition of theophylline. While adding rifampicin 20
or 40 s prior to adding theophylline reduces the overall
level of b-galactosidase activity, as would be expected
from the inhibition of mRNA synthesis, the onset of b-
galactosidase activity occurs at the same time (200 s)
as it does in the absence of rifampicin. Assuming that ri-
fampicin acts within 5 s and that E. coli RNA polymerase
transcribes mRNA at 60 nt/s [39], by adding rifampicin
40 s prior to theophylline, no new transcripts should be
synthesized, and any elongating transcripts should be
>1800 nt long, far beyond the 100 nt 50UTR containing
the riboswitch, at the time that theophylline is added.
Though we cannot easily determine how quickly theophyl-
line enters the cell and reaches an effective concentration,
we can consider two limiting scenarios: theophylline
enters essentially immediately or theophylline entry is de-
layed by up to 200 s. If theophylline enters the cell imme-
diately, the cotranscriptional model predicts that b-galac-
tosidase activity should begin to appear within 60 s, which
is the time required for translation and folding of b-
galactosidase. However, b-galactosidase activity does
not appear until nearly 200 s after the addition of theoph-
ylline, which argues against the cotranscriptional model if
theophylline entry is fast. If theophylline entry is slow (up to
140 s), the cotranscriptional model becomes even less
tenable because after 140 s, all transcripts should be com-
pleted, regardless of the time of addition of rifampicin. The
fact that b-galactosidase activity continues to increase
steadily long after the addition of theophylline, and
>300 s after the addition of rifampicin (Figure 7C), argues
against a cotranscriptional model for the activation of
expression and is more consistent with a model in which
theophylline induces a conformational change in an exist-
ing mRNA.
Since the data support an equilibrium model in which
theophylline induces conformational changes, one might
expect that ligand-dependent changes could be observed
through RNA footprinting studies. To test this possibility,
we performed in vivo footprinting experiments by using
the SHAPE method developed by Weeks and coworkers
[40]. In the SHAPE method, N-methylisatoic anhydride
(NMIA) modifies the 20-OH of RNA depending on the local
nucleotide flexibility [40]. These modifications of an RNA
template cause the enzyme reverse transcriptase to
pause and dissociate, leading to truncations at the site
immediately 30 to the modified ribose. By comparing the
products of a reverse-transcription reaction against a
known sequence standard by gel electrophoresis, oneChemistry & Biology 14, 173–can map the location of modifications, as well as the ex-
tent of modification.
We added NMIA to cells harboring a synthetic ribo-
switch that were grown in the presence or absence of
1 mM theophylline. The modified total RNA was extracted
and used as a template for reverse transcription. The tran-
scription reactions were separated by gel electrophoresis
and the pausing due to NMIA modification in the presence
and absence of ligand was analyzed. Though we ob-
served NMIA modification of RNA that was not present
in an untreated control, we were not able to visualize sub-
stantial differences in NMIA modification between cells
grown in the presence or absence of theophylline.
SHAPE experiments integrate the total RNA population,
not just the fraction of mRNAs that are potentially translat-
able, and it may be difficult to detect a small increase in
translatable mRNAs against a large background of non-
translatable mRNAs. To assess the fraction of mRNAs
that are translating in vivo, we compared the levels of b-
galactosidase expression between a riboswitch-contain-
ing construct (clone 8.1) and a construct that shared the
same ribosome binding site from 8.1 but lacked the ap-
tamer. The construct lacking the aptamer expressed ap-
proximately six times more b-galactosidase than the
riboswitch-containing construct grown in the presence
of 1 mM theophylline. This is consistent with the idea
that theophylline induces translation of 16% of the tran-
scripts, but that 84% may remain inactive. Since SHAPE
(and other methods that integrate results over entire pop-
ulations) cannot distinguish between translating and non-
translating mRNAs, the majority of labeled RNA would be
expected to be nontranslating, and a small increase in
translating RNAs will likely not be visible. While other
in vitro experiments such as nuclease digestion under
thermodynamically controlled conditions (renaturing, long
time scales) might glean further structural information, it
is not immediately clear that this information would be
directly relevant to the actual behavior inside the cell.
Finally, we note that for an ‘‘on’’ switch, there is no a priori
reason to assume that full activation of translation is nec-
essary or even desirable for function in either synthetic
or natural riboswitches. Indeed, we have observed ribo-
switches that activate more fully (e.g., the parent switch
in Figure 3E), but such switches may face a trade off
between leaky expression and high-absolute levels of
activation.
Possible Design Implications for Synthetic
Riboswitches
While the generality of this equilibrium model will be inves-
tigated in future studies, in its current form, the model may
provide guidelines for the design of synthetic riboswitches
that activate protein translation. In particular, the model
suggests that it will be critical to balance the relative free
energies of ‘‘off state,’’ the ligand-free ‘‘on state,’’ and
the ligand-bound ‘‘on state.’’ Since the energy differences
of the ligand-free ‘‘on state’’ and the ligand-bound ‘‘on
state’’ are dictated by the free energy of ligand binding
to the aptamer, this puts thermodynamic constraints on184, February 2007 ª2007 Elsevier Ltd All rights reserved 181
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the ‘‘off state’’ is close to that of the ligand-free ‘‘on state’’
(and there is interconversion), background translation in
the absence of the ligand will be high. However, if the
‘‘off state’’ is very stable, binding of ligand may not result
in a sufficient population of the ligand-bound ‘‘on state’’ to
allow translation, even if this state is highly translatable.
We anticipate that this model may help guide the design
of future synthetic riboswitches.
Possible Evolutionary Implications for Natural
Riboswitches
Our results show that beginning with an aptamer se-
quence that recognizes a small molecule, it is relatively
straightforward to create synthetic riboswitches. Indeed,
we have discovered a variety of high-performing synthetic
riboswitches where both the length and composition of
the sequence between the aptamer and the ribosome
binding site vary considerably. Furthermore, we have
identified two functional motifs where the bases between
the aptamer and the ribosome binding site pair to distinct
regions of the aptamer, and retrospective analysis of a pre-
viously reported synthetic riboswitch reveals a third motif
where these bases pair to part of the coding sequence to
repress translation in the absence of the ligand. Taken to-
gether, our results show that there are many straightfor-
ward ways to generate synthetic riboswitches by inserting
an aptamer sequence into the 50UTR of a gene. Via rela-
tively few base changes, the dynamic ranges of these
switches can be improved dramatically to give sensitive
ligand-dependent genetic control elements. It has been
suggested that natural riboswitches may be molecular
fossils from an RNA world [7], where RNA sequences
that once served to bind to ligands (perhaps as cofactors
for RNA catalysis), have since been co-opted for the pur-
pose of gene regulation. Our results show that it is rela-
tively straightforward on the laboratory timescale to con-
vert an aptamer into a synthetic riboswitch. We suggest
that by using similar mechanisms, nature may have
evolved riboswitches from pre-existing aptamers.
SIGNIFICANCE
Riboswitches are RNA-based genetic control ele-
ments that activate or repress gene expression in
a small-molecule-dependent fashion without the
need for proteins. The ability to create synthetic ribo-
switches that control gene expression in response to
any desired small molecule could enable the develop-
ment of sensitive genetic screens and selections to
detect the presence of small molecules, as well as
the creation of designer genetic control elements for
studying cell function or conditional gene therapy. Ri-
boswitches require an aptamer to recognize the de-
sired molecule and a mechanism for converting this
sensing event into a change in gene expression. While
methods to discover aptamers that selectively bind
small molecules are well established, methods of con-
verting these aptamers to synthetic riboswitches that182 Chemistry & Biology 14, 173–184, February 2007 ª2007 Efunction optimally in cells are not. We have presented
an automated high-throughput screening method that
identifies synthetic riboswitches that show extremely
low background levels of gene expression in the ab-
sence of ligand and robust increases in expression in
the presence of the desired ligand. These synthetic ri-
boswitches not only show superior performance rela-
tive to previously reported switches but also compare
favorably to natural riboswitches. Sequence informa-
tion allowed us to propose and test a model for ribos-
witch function that explains the mechanism of action
for these and previously described synthetic ribo-
switches. Furthermore, we have proposed a simple
model for synthetic riboswitches that activate protein
translation that may guide future experiments. Our re-
sults show that beginning with a known aptamer, it is
straightforward to create distinct families of synthetic
riboswitches, which is consistent with the idea that
natural riboswitches may have evolved from small-
molecule-binding aptamers that were retained from
an RNA world and subsequently recruited to become
genetic regulation elements. We anticipate that this
high throughput method will be generally useful for




All plasmid manipulations utilized standard cloning techniques [41]. All
constructs have been verified by DNA sequencing at the NSF-sup-
ported Center for Fundamental and Applied Molecular Evolution at
Emory University. Purifications of plasmid DNA, PCR products, and
enzyme digestions were performed with kits from QIAGEN. Theophyl-
line, o-nitrophenyl-b-D-galactopyranoside (ONPG), ampicillin, and
chloramphenicol were purchased from Sigma. X-gal was purchased
from US Biological. Synthetic oligonucleotides were purchased from
IDT. All experiments were performed in E. coli TOP10 F0 cells (Invitro-
gen) cultured in media obtained from EMD Bioscience.
Construction of Randomized Libraries
Libraries were constructed by oligonucleotide-based cassette muta-
genesis. Mutagenic primers with degenerate regions were designed
to create cassettes with randomized sequences of appropriate lengths
between the mTCT8-4 theophylline aptamer [24] and the RBS of the
IS10-lacZ reporter gene. Full descriptions of the mutagenesis strate-
gies, primer sequences, and plasmid features are available in the Sup-
plemental Data.
Library Screens
Library transformations were plated on large (241 mm3 241 mm) bio-
assay trays from Nalgene containing LB/agar (300 ml) supplemented
with ampicillin (50 mg/ml) and X-Gal (25 mg dissolved in 4.0 ml dimethyl
formamide, final concentration 0.008%). Cells were plated to achieve
a final density of 4,000 colonies/plate. Cells were grown for 14 hr at
37C, followed by incubation at 4C until blue color was readily visible.
The whitest colonies from each plate were picked by using a Genetix
QPix2 colony picking robot and were inoculated in a 96-well microtiter
plate (Costar), which contained LB media (200 ml/well) supplemented
with ampicillin (50 mg/ml). The plate was incubated overnight at 37C
with shaking (180 rpm). The following day, four 96-well plates (two
sets of two) were inoculated with 2 ml of the overnight culture. The
first set of plates contained 200 ml LB supplemented with ampicillin
(50 mg/ml). The second set of plates contained 200 ml LBlsevier Ltd All rights reserved
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High-Throughput Screen for Synthetic Riboswitchessupplemented with both ampicillin (50 mg/ml) and theophylline
(0.5 mM). Plates were incubated for approximately 2.5 hr at 37C
with shaking (210 rpm) to an OD600 of 0.085–0.14 as determined by
a Biotek microplate reader. These values correspond to an OD600 of
0.3–0.5 with a 1 cm path length cuvette.
A high-throughput microtiterplate assay for b-galactosidase activity
was adapted from previously described methods [29–31]. Cultures
were lysed by adding Pop Culture solution (Novagen, 21 ml, 10:1,
Pop Culture: lysozyme [4 U/ml]), mixed by pipetting up and down,
and allowed to stand at room temperature for 5 min. In a fresh plate,
15 ml of lysed culture was combined with Z buffer (132.25 ml, 60 mM
Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50 mM b-mer-
captoethanol [pH 7.0]). This was followed by addition of ONPG (29 ml,
4 mg/ml in 100 mM NaH2PO4). ONPG was allowed to hydrolyze for
approximately 20 min or until faint yellow color was observed. The
reaction was quenched by the addition of Na2CO3 (75 ml of a 1 M
solution). The length of time between substrate addition and quench-
ing was recorded and the OD420 for each well was determined. The
Miller units were calculated by using the following formula:
Miller units=OD420=ðOD6003hydrolysis time
3 ½volume of cell lysate=total volumeÞ
Ratios of the Miller units for cultures grown in the presence or absence
of theophylline represent an ‘‘activation ratio.’’ The initial pool of candi-
date switches comprised clones that showed an activation ratio of
greater than 2.0 in two separate determinations. Candidates that did
not display a minimum activity in the presence of theophylline (an
OD420R 0.04) in either determination were eliminated from consider-
ation. As a final check, we visually inspected the data for aberrations,
such as cultures that grew especially slowly or quickly (as represented
by OD600), or for cultures with dramatically different results between
the two plates. Clones that were identified as potential switches
were subcultured and assayed as previously described.
Rifampicin Assay
An aliquot of a saturated overnight culture (500 ml) was used to inocu-
late 50 ml of LB supplemented with ampicillin (50 mg/ml). The fresh cul-
ture was grown with shaking (300 rpm, 37C) to an OD600 of 0.4–0.5
(approximately 2.75 hr). The culture was split into two 16.6 ml fractions.
Theophylline (50 mg/ml in DMSO, warmed to 37C) and rifampicin
(50 mg/ml in DMSO) were added as appropriate to one of the cultures
such that the final concentrations were 3.0 M theophylline, 250 mg/ml
rifampicin; the other culture was used as a control. Aliquots of the cul-
tures (4 3 100 ml each) were collected at 20, 40, or 100 s intervals by
using a Freedom-EVO liquid-handling system (TECAN) and were
transferred to individual wells of a 96-well microtiter plate that were
prefilled with Pop Culture (10 ml). A 30 ml aliquot from each well of lysed
cells was added to 119 ml of Z buffer in a microtiter plate (see above).
ONPG (29 ml, 4 mg/ml in 100 mM NaH2PO4) was added and was
allowed to hydrolyze for 1 hr at 30C, followed by quenching with
Na2CO3 (75 ml of a 1 M solution). The OD420 for each well was
determined.
Supplemental Data
Supplemental Data include the sequences of all synthetic ribo-
switches, experimental details of the NMIA labeling protocol, and de-
tails of the computational RNA-folding procedure and are available at
http://www.chembiol.com/cgi/content/full/14/2/173/DC1/.
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